0001477932-24-000417.txt : 20240126
0001477932-24-000417.hdr.sgml : 20240126
20240126160549
ACCESSION NUMBER: 0001477932-24-000417
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240124
FILED AS OF DATE: 20240126
DATE AS OF CHANGE: 20240126
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Forterre Gael
CENTRAL INDEX KEY: 0001841637
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36833
FILM NUMBER: 24567751
MAIL ADDRESS:
STREET 1: 1489 WEST WARM SPRINGS ROAD
STREET 2: SUITE 110
CITY: HENDERSON
STATE: NV
ZIP: 89014
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VOLITIONRX LTD
CENTRAL INDEX KEY: 0000093314
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 911949078
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1489 WEST WARM SPRINGS ROAD
STREET 2: SUITE 110
CITY: HENDERSON
STATE: NV
ZIP: 89014
BUSINESS PHONE: 1 (646) 650-1351
MAIL ADDRESS:
STREET 1: 1489 WEST WARM SPRINGS ROAD
STREET 2: SUITE 110
CITY: HENDERSON
STATE: NV
ZIP: 89014
FORMER COMPANY:
FORMER CONFORMED NAME: STANDARD CAPITAL CORP
DATE OF NAME CHANGE: 19990812
4
1
form4.xml
FORM 4
X0508
4
2024-01-24-05:00
false
0000093314
VOLITIONRX LTD
VNRX
0001841637
Forterre Gael
1489 WEST WARM SPRINGS ROAD
SUITE 110
HENDERSON
NV
89014
false
true
false
false
Chief Commercial Officer
false
Common Stock
2024-01-24-05:00
4
A
false
25925
0
A
128176
D
Common Stock
5000
I
By Spouse
Common Stock
32500
I
By Armori Capital Management, LLC
On September 28, 2023, the reporting person was awarded 61,000 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2023 and June 30, 2024 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 25,925 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three installments of 8,642 units, 8,642 units, and 8,641units on each of September 28, 2024, September 28, 2025 and September 28, 2026, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.
These shares of common stock are managed by Armori Capital Management, LLC ("Armori Capital"). Mr. Forterre is the managing director and sole shareholder of Armori Capital and has voting and dispositive control over the shares held by Armori Capital. Mr. Forterre disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
/s/ Gael Forterre
2024-01-26-05:00